Journal of Clinical Medicine,
Journal Year:
2023,
Volume and Issue:
12(11), P. 3791 - 3791
Published: May 31, 2023
Chronic
obstructive
pulmonary
disease
(COPD)
is
significant
cause
of
morbidity
and
mortality
worldwide.
There
mounting
evidence
suggesting
that
COPD
patients
are
at
increased
risk
severe
COVID-19
outcomes;
however,
it
remains
unclear
whether
they
more
susceptible
to
acquiring
SARS-CoV-2
infection.
In
this
comprehensive
review,
we
aim
provide
an
up-to-date
perspective
the
intricate
relationship
between
COVID-19.
We
conducted
a
thorough
review
literature
examine
regarding
susceptibility
infection
severity
their
outcomes.
While
most
studies
have
found
pre-existing
associated
with
worse
outcomes,
some
yielded
conflicting
results.
also
discuss
confounding
factors
such
as
cigarette
smoking,
inhaled
corticosteroids,
socioeconomic
genetic
may
influence
association.
Furthermore,
acute
management,
treatment,
rehabilitation,
recovery
in
how
public
health
measures
impact
care.
conclusion,
while
association
complex
requires
further
investigation,
highlights
need
for
careful
management
during
pandemic
minimize
European Respiratory Review,
Journal Year:
2024,
Volume and Issue:
33(171), P. 230137 - 230137
Published: Jan. 31, 2024
COPD
poses
a
significant
global
public
health
challenge,
primarily
characterised
by
irreversible
airflow
restriction
and
persistent
respiratory
symptoms.
The
hallmark
pathology
of
includes
sustained
airway
inflammation
the
eventual
destruction
lung
tissue
structure.
While
multiple
risk
factors
are
implicated
in
disease's
progression,
underlying
mechanisms
remain
largely
elusive.
perpetuation
is
pivotal
to
advancement
COPD,
emphasising
importance
investigating
these
self-sustaining
for
deeper
understanding
pathogenesis.
Autoimmune
responses
constitute
critical
mechanism
maintaining
inflammation,
with
burgeoning
evidence
pointing
their
central
role
progression;
yet,
intricacies
inadequately
defined.
This
review
elaborates
on
supporting
presence
autoimmune
processes
examines
potential
through
which
may
drive
chronic
characteristic
disease.
Moreover,
we
attempt
interpret
clinical
manifestations
autoimmunity.
BMJ Open Respiratory Research,
Journal Year:
2025,
Volume and Issue:
12(1), P. e002694 - e002694
Published: Feb. 1, 2025
Background
Chronic
obstructive
pulmonary
disease
(COPD)
is
a
risk
factor
for
severe
COVID-19.
However,
mortality
after
COVID-19
recovery
in
this
population
remains
unclear.
Methods
We
retrospectively
enrolled
individuals
with
COPD
from
the
Korean
National
Health
Insurance
database.
compared
rate
who
recovered
between
8
October
2020
and
31
December
2021
(COVID-19
cohort,
n=2499)
that
1:1
propensity
score-matched
controls
(n=2499).
The
study
was
followed
until
either
death
or
30
September
2022,
whichever
came
first.
Results
cohort
had
4.8%
vs
2.7%
matched
during
median
follow-up
of
319
days
(IQR,
293–422
days),
including
14
time.
higher
than
(adjusted
HR
(aHR)=1.81,
95%
CI=1.35
to
2.45).
notably
(aHR=5.05,
CI=3.65
6.97),
especially
first
180
(highest
(aHR=20.25,
CI=7.79
52.64)).
Non-severe
does
not
increase
(aHR=0.85,
CI=0.57
1.28).
Conclusion
Individuals
recovering
showed
an
increased
long-term
mortality,
particularly
within
post-recovery,
those
experienced
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(4), P. 973 - 973
Published: April 21, 2023
Oxidative
stress
is
a
major
hallmark
of
COPD,
contributing
to
inflammatory
signaling,
corticosteroid
resistance,
DNA
damage,
and
accelerated
lung
aging
cellular
senescence.
Evidence
suggests
that
oxidative
damage
not
solely
due
exogenous
exposure
inhaled
irritants,
but
also
endogenous
sources
oxidants
in
the
form
reactive
oxygen
species
(ROS).
Mitochondria,
producers
ROS,
exhibit
impaired
structure
function
resulting
reduced
capacity
excessive
ROS
production.
Antioxidants
have
been
shown
protect
against
ROS-induced
by
reducing
levels,
inflammation,
protecting
development
emphysema.
However,
currently
available
antioxidants
are
routinely
used
management
suggesting
need
for
more
effective
antioxidant
agents.
In
recent
years,
number
mitochondria-targeted
(MTA)
compounds
developed
capable
crossing
mitochondria
lipid
bilayer,
offering
targeted
approach
at
its
source.
particular,
MTAs
illicit
greater
protective
effects
compared
non-targeted,
further
apoptosis
protection
mtDNA
they
promising
therapeutic
agents
treatment
COPD.
Here,
we
review
evidence
potential
as
chronic
disease
discuss
current
challenges
future
directions.
Journal of Cellular and Molecular Medicine,
Journal Year:
2024,
Volume and Issue:
28(17)
Published: Sept. 1, 2024
Abstract
Cathepsin
B
(CTSB)
is
a
member
of
the
cysteine
protease
family,
primarily
responsible
for
degrading
unnecessary
organelles
and
proteins
within
acidic
milieu
lysosomes
to
facilitate
recycling.
Recent
research
has
revealed
that
CTSB
plays
multifaceted
role
beyond
its
function
as
proteolytic
enzyme
in
lysosomes.
Importantly,
recent
data
suggest
significant
impacts
on
different
cardiac
pathological
conditions,
such
atherosclerosis
(AS),
myocardial
infarction,
hypertension,
heart
failure
cardiomyopathy.
Especially
context
AS,
preclinical
models
clinical
sample
imaging
indicate
cathepsin
activity‐based
probe
can
reliably
image
activity
foam
cells
atherosclerotic
plaques;
concurrently,
it
allows
synchronous
diagnostic
therapeutic
interventions.
However,
our
knowledge
cardiovascular
disease
still
early
stage.
This
paper
aims
provide
comprehensive
review
significance
physiology
pathology,
with
objective
laying
theoretical
groundwork
development
drugs
targeting
CTSB.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Dec. 10, 2022
Chronic
obstructive
pulmonary
disease
(COPD)
is
characterised
by
airflow
limitation
and
infective
exacerbations,
however,
in-vitro
model
systems
for
the
study
of
host-pathogen
interaction
at
individual
level
are
lacking.
Here,
we
describe
establishment
nasopharyngeal
bronchial
organoids
from
healthy
individuals
COPD
that
recapitulate
level.
In
contrast
to
organoids,
goblet
cell
hyperplasia
reduced
ciliary
beat
frequency
were
observed
in
hallmark
features
disease.
Single-cell
transcriptomics
uncovered
evidence
altered
cellular
differentiation
trajectories
organoids.
SARS-CoV-2
infection
revealed
more
productive
replication
bronchi,
key
site
severe
COVID-19.
Viral
bacterial
exposure
induced
greater
pro-inflammatory
responses
summary,
present
an
organoid
recapitulates
vivo
physiological
lung
microenvironment
amenable
emerging
infectious
American Journal of Respiratory and Critical Care Medicine,
Journal Year:
2023,
Volume and Issue:
208(10), P. 1075 - 1087
Published: Sept. 14, 2023
IL-33
is
a
proinflammatory
cytokine
thought
to
play
role
in
the
pathogenesis
of
asthma
and
chronic
obstructive
pulmonary
disease
(COPD).
A
recent
clinical
trial
using
an
anti-IL-33
antibody
showed
reduction
exacerbation
improved
lung
function
ex-smokers
but
not
current
smokers
with
COPD.
American Journal of Respiratory and Critical Care Medicine,
Journal Year:
2024,
Volume and Issue:
210(10), P. 1219 - 1229
Published: April 16, 2024
Background.
Chronic
Obstructive
Pulmonary
Disease
(COPD)
is
a
heterogeneous
condition.
We
hypothesized
that
the
unbiased
integration
of
different
COPD
lung
omics
using
novel
multi-layer
approach
may
unravel
mechanisms
associated
with
clinical
characteristics.
Methods.
profiled
mRNA,
miRNA
and
methylome
in
tissue
samples
from
135
former
smokers
COPD.
For
each
omic
(layer)
we
built
patient
network
based
on
molecular
similarity.
The
three
networks
were
used
to
build
network,
optimization
multiplex-modularity
was
employed
identify
communities
across
distinct
layers.
Uncovered
related
features.
Results.
identified
five
which
molecularly
characteristics,
such
as
FEV1
blood
eosinophils.
Two
(C#3
C#4)
had
both
similarly
low
values
emphysema,
but
different:
C#3,
not
C#4,
presented
B
T
cell
signatures
downregulation
secretory
(SCGB1A1/SCGB3A1)
ciliated
cells.
A
machine
learning
model
set
up
discriminate
C#3
C#4
our
cohort,
validate
them
an
independent
cohort.
Finally,
spatial
transcriptomics
characterized
small
airway
differences
between
identifying
upregulation
T/B
homing
chemokines,
bacterial
response
genes
C#3.
Conclusions.
analysis
able
clinically
relevant
communities.
Patients
emphysema
can
have
airways
immune
patterns,
indicating
endotypes
lead
similar
presentation.